Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Tyrrell

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
The Journal of Infectious Diseases|November 1, 1992
Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorderJ K Preiksaitis, F Diaz-Mitoma, F Mirzayans, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1989
In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirusB Lee, W X Luo, S Suzuki, et al.
Molecular Pharmacology|March 1, 1987
A proposed mechanism for the selective inhibition of human cytomegalovirus replication by 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-fluorouracilS Suzuki, H K Misra, L I Wiebe, et al.
Canadian Medical Association Journal|June 18, 1977
Listeria monocytogenes endophthalmitis in an immune-suppressed hostJ Nigrin, D L Tyrrell, F L Jackson, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1984
Quantitative uptake studies of 131I-labeled (E)-5-(2-iodovinyl)-2'-deoxyuridine in herpes simplex virus-infected cells in vitroM J Gill, J Samuel, L I Wiebe, et al.
Biochemical and Biophysical Research Communications|November 15, 1988
Inhibition of duck hepatitis B virus replication by purine 2',3'-dideoxynucleosidesS Suzuki, B Lee, W Luo, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|August 19, 2000
In vitro anti-hepatitis B virus activities of 5"-O-myristoyl analogue derivatives of 3"-fluoro-2",3"-dideoxythymidine (FLT) and 3"-azido-2",3"-dideoxythymidine (AZT)K Parang, L I Wiebe, E E Knaus, et al.
Vaccine|December 1, 1989
Antibodies to measles virus surface polypeptides in an immunized student population before and after booster vaccinationM J Mäkelä, R G Marusyk, E Norrby, et al.
Journal of Medicinal Chemistry|October 5, 2001
Synthesis and antiviral activity of novel 5-(1-cyanamido-2-haloethyl) and 5-(1-hydroxy(or methoxy)-2-azidoethyl) analogues of uracil nucleosidesR Kumar, D Rai, S K Sharma, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 1, 1987
A case of acquired immune deficiency syndrome before 1980E Rogan, L D Jewell, B W Mielke, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
The Journal of Infectious Diseases|November 1, 1992
Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorderJ K Preiksaitis, F Diaz-Mitoma, F Mirzayans, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1989
In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirusB Lee, W X Luo, S Suzuki, et al.
Molecular Pharmacology|March 1, 1987
A proposed mechanism for the selective inhibition of human cytomegalovirus replication by 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-fluorouracilS Suzuki, H K Misra, L I Wiebe, et al.
Canadian Medical Association Journal|June 18, 1977
Listeria monocytogenes endophthalmitis in an immune-suppressed hostJ Nigrin, D L Tyrrell, F L Jackson, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1984
Quantitative uptake studies of 131I-labeled (E)-5-(2-iodovinyl)-2'-deoxyuridine in herpes simplex virus-infected cells in vitroM J Gill, J Samuel, L I Wiebe, et al.
Biochemical and Biophysical Research Communications|November 15, 1988
Inhibition of duck hepatitis B virus replication by purine 2',3'-dideoxynucleosidesS Suzuki, B Lee, W Luo, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|August 19, 2000
In vitro anti-hepatitis B virus activities of 5"-O-myristoyl analogue derivatives of 3"-fluoro-2",3"-dideoxythymidine (FLT) and 3"-azido-2",3"-dideoxythymidine (AZT)K Parang, L I Wiebe, E E Knaus, et al.
Vaccine|December 1, 1989
Antibodies to measles virus surface polypeptides in an immunized student population before and after booster vaccinationM J Mäkelä, R G Marusyk, E Norrby, et al.
Journal of Medicinal Chemistry|October 5, 2001
Synthesis and antiviral activity of novel 5-(1-cyanamido-2-haloethyl) and 5-(1-hydroxy(or methoxy)-2-azidoethyl) analogues of uracil nucleosidesR Kumar, D Rai, S K Sharma, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 1, 1987
A case of acquired immune deficiency syndrome before 1980E Rogan, L D Jewell, B W Mielke, et al.
Pageof 9